Governments, Private Sector Should Pilot Incentive Programs For New Antibiotic, Vaccine, Diagnostic R&D

Project Syndicate: Turning AMR Words Into Action
Jim O’Neill, honorary professor of economics at Manchester University and former chair of the Review on Antimicrobial Resistance

“…The [U.K. government’s Review on Antimicrobial Resistance (AMR)] showed that even as the world runs out of effective antibiotics, we are overusing those that still work. … In the Review’s final recommendations, increasing public awareness was one of our Ten Commandments. … Among the other Ten Commandments on which some progress has been made, I am particularly excited about three. First, a promising amount of money is flowing into early-stage research and development … Second, more researchers seem to be focusing on AMR … And, third, the misuse of antibiotics in agriculture has been reduced more than I would have expected … Unfortunately, action has been lacking in the development of new diagnostics, vaccines (and vaccine alternatives), and antibiotics. Since the Review published its final report, there has been a lot of talk about these three crucial recommendations, particularly from the pharmaceutical industry. … And yet no concrete action has been taken. To change that, the top 20 antibiotics producers could ask their respective governments to ‘pilot’ a funding mechanism for taking new drugs through clinical trials and to market. … We also recommended that those developing new vaccines or alternatives and state-of-the-art diagnostics be eligible for … rewards…” (11/27).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.